She is fine now but she heard that I should get a mammogram at 25 since she has a history of breast cancer . Is this true?
When should I have a mammogram. My mom had breast cancer …breast-cancer-treatments.net
WASHINGTON (Reuters) - Insurers and employers will have to spell out plainly the costs and benefits of the health plans they offer starting next year.The rule announced by U.S. health officials on Wednesday is designed to better inform people about health insurance choices with a standard label, which the Department of Health and Human Services likens to the kind on a cereal box.Among other things, the label will tell customers their premium, deductible and out-of-pocket costs, and the costs associated with medical events and procedures such as doctor visits and breast cancer treatments."Today, many consumers don't have easy access to information in plain English to help them understand the differences in the coverage and benefits provided by different health plans," said HHS Secretary Kathleen Sebelius.The rule, part of President Barack Obama's 2010 health care overhaul, pleases consumer groups who complain that the pages of fine print accompanying insurance plans are often confusing."By making the terms of health insurance plans easier to understand, consumers are less likely to find themselves in health plans that don't meet their needs," said Consumers Union senior health policy analyst Lynn Quincy.Insurers are concerned that the administrative costs associated with these labels will raise the price of the plans themselves.Kim Holland, executive director of state affairs at Blue Cross Blue Shield Association, said insurers support people knowing what they are getting, but echoed that concern."The concern is we already have a body of law that tells us what we need to have," Holland said before the rule's release.The six-page labels follow the recommendations of a group formed by the National Association of Insurance Commissioners that included insurance companies, consumer groups and academics."At the end of the day, what NAIC recommended wasn't what everybody wanted, but it was as close to a consensus as possible," said Sabrina Corlette, an NAIC consumer representative and Georgetown University research professor."You wouldn't be comparing apples to oranges anymore," she said. "So it would make it much easier for families to make those decisions." feedproxy.google.com
freenutrition: Prostate Cancer Treatments Australia- Dexter Dunphy http:p.ost.impeJvqbV-- · Replyhealthwet: Five Common Breast Cancer Treatments - http:onlinehealth.cz.ccjc - Healthylife-- · Replyjawasy: New Non-toxic Cancer Treatments http:www.topreventbreastcancer.comnew-non-toxic-cancer-treatments.html-- · ReplyBlackSeedHealth: Four Stories of Cancer Treatments: One Uses Nigella Sativa: http:dld.bztDeU-- · ReplySharonTSFCCFox: cancer centre open day, free taster tr cancerpreventionblog.net
Among women with HER2-positive breast cancer that has spread to the brain, treatment with Herceptin® (trastuzumab) and/or chemotherapy can prolong survival. These results were published in Clinical Cancer Research.
Although important advances have been made in breast cancer treatment, the treatment of metastatic breast cancer (breast cancer that has spread to other parts of the body) remains challenging. The brain is one area to which breast cancer may spread, and researchers continue to explore how best to manage patients with brain metastases.
To assess the frequency and outcome of brain metastases in women with metastatic HER2-positive breast cancer, researchers conducted a study among 1,023 newly diagnosed patients. HER2-positive breast cancer refers to cancer that overexpresses (makes too much of) the HER2 protein. Treatment of HER2-positive breast cancer often includes a HER2-targeted therapy such as Herceptin.
Brain metastases were more common in younger women, those with hormone receptor-negative breast cancer, and those with a greater amount of cancer.
Among women who were free of brain metastases at the time of their initial diagnosis but later developed brain metastases, brain metastases were diagnosed a median of 13 months after initial diagnosis.
After the diagnosis of brain metastases, treatment with Herceptin and chemotherapy each significantly improved overall survival.
These results suggest that even after HER2-positive breast cancer spreads to the brain, standard breast cancer treatments can prolong survival.
Reference: Brufsky AM, Mayer M, Rugo HS et al. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER. Clinical Cancer Research. 2011; 17: 4834–43. news.cancerconnect.com
You can link to this article on your web site using following code:
We're looking for comments that are interesting, substantial or highly amusing. If your comments are excessively self-promotional (use your real name, no keywords please), obnoxious, or even worse, boring, you will be banned from commenting. Your comment must be related to the post. Please do not comment on how great or wonderful the post is. All comments are moderated and, if approved, will display in less than 24 hours.